Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2020-09-25 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. Specifically, it details an 'acquisition or disposal of voting rights' by 'Kempen Capital Management N.V.' resulting in a holding of '5.01%'. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2020-09-25 English
Grant of Options to Directors
Director's Dealing Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 0422A) on September 24, 2020. The content explicitly details the 'Grant of Options to Directors' (PDMRs) and includes mandatory disclosure tables required under EU Market Abuse Regulation concerning transactions by persons discharging managerial responsibilities. This type of filing, which reports insider transactions (specifically option grants to executives), falls under the category of Director's Dealing (DIRS). While it involves remuneration elements, the core focus is the transaction/holding change by directors, making DIRS the most precise fit over DEF 14A (which is typically a full remuneration report).
2020-09-24 English
Interim Results
Earnings Release Classification · 100% confidence The document explicitly states it contains 'Interim results for the six months ended 30 June 2020'. It provides a detailed financial summary table covering revenue, EBITDA, profit before tax, and EPS for H1 2020 compared to H1 2019. This structure and content clearly identify it as a comprehensive financial report for a period shorter than a year. This matches the definition of an Interim / Quarterly Report (IR). Although it is released via RNS (RNS Number: 6431Z), the content itself is the full report, not just an announcement of the report's publication. H1 2020
2020-09-22 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a short regulatory announcement (3901 characters) released via RNS (RNS Number : 8426X) on September 2, 2020. The content explicitly states it is a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, providing the 'Total Voting Rights' as of a specific date (28 August 2020). This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory filing that does not fit into the specific categories like 10-K, ER, or IR. Since it is a formal regulatory announcement that doesn't fit a more specific category (like DIRS or DIV), it falls best under the general 'Regulatory Filings' category (RNS), which serves as a fallback for mandatory, non-specific disclosures.
2020-09-02 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. Key indicators include 'RNS Number', 'Identity of the issuer', 'Reason for the notification', 'Date on which the threshold was crossed or reached', and 'Total positions of person(s) subject to the notification obligation' showing percentage changes (e.g., from 8.3% to 7.3%). This directly corresponds to the definition of a Major Shareholding Notification, which is classified under the code MRQ in the provided schema.
2020-08-26 English
Notification of Half Year Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (4030 characters) released via RNS (RNS Number: 1365X) from Alliance Pharma PLC. The core content is the notification that the company 'will announce its results for the six months ended 30 June 2020 on Tuesday 22 September 2020' and provides details about the subsequent analyst conference call and webcast. This fits the definition of announcing the publication of a report rather than being the report itself. Since it is a formal announcement regarding the release of financial results (Half Year Results), the most specific category is Report Publication Announcement (RPA). If RPA were not available, RNS would be the fallback, but RPA is a better fit for announcements about scheduled report releases.
2020-08-26 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.